Present Status and Future Prospects for Adjuvant Therapy of Melanoma: Time to Build upon the Foundation of High-dose Interferon Alfa-2b The high cure rates for patients with Hodgkin's Disease (HD) in ...
When considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果